Treatment decisions under ambiguity
- PMID: 23537710
- DOI: 10.1016/j.jhealeco.2013.02.001
Treatment decisions under ambiguity
Abstract
Many health risks are ambiguous in the sense that reliable and credible information about these risks is unavailable. In health economics, ambiguity is usually handled through sensitivity analysis, which implicitly assumes that people are neutral towards ambiguity. However, empirical evidence suggests that people are averse to ambiguity and react strongly to it. This paper studies the effects of ambiguity aversion on two classical medical decision problems. If there is ambiguity regarding the diagnosis of a patient, ambiguity aversion increases the decision maker's propensity to opt for treatment. On the other hand, in the case of ambiguity regarding the effects of treatment, ambiguity aversion leads to a reduction in the propensity to choose treatment.
Copyright © 2013 Elsevier B.V. All rights reserved.
Similar articles
-
Source preference and ambiguity aversion: models and evidence from behavioral and neuroimaging experiments.Adv Health Econ Health Serv Res. 2008;20:179-201. Adv Health Econ Health Serv Res. 2008. PMID: 19552309
-
Allocating health care resources when people are risk averse with respect to life time.Health Econ. 2003 Jul;12(7):601-8. doi: 10.1002/hec.733. Health Econ. 2003. PMID: 12825211
-
Ambiguous games: evidence for strategic ambiguity aversion.Q J Exp Psychol (Hove). 2007 Aug;60(8):1083-100. doi: 10.1080/17470210600866354. Q J Exp Psychol (Hove). 2007. PMID: 17654393
-
A dual system model of preferences under risk.Psychol Rev. 2010 Jan;117(1):243-55. doi: 10.1037/a0017884. Psychol Rev. 2010. PMID: 20063971 Review.
-
Risk management frameworks for human health and environmental risks.J Toxicol Environ Health B Crit Rev. 2003 Nov-Dec;6(6):569-720. doi: 10.1080/10937400390208608. J Toxicol Environ Health B Crit Rev. 2003. PMID: 14698953 Review.
Cited by
-
Threshold analysis in the presence of both the diagnostic and the therapeutic risk.Eur J Health Econ. 2018 Sep;19(7):1019-1026. doi: 10.1007/s10198-017-0951-1. Epub 2017 Dec 26. Eur J Health Econ. 2018. PMID: 29280041
-
Comment on: "Healthy Decisions: Towards Uncertainty Tolerance in Healthcare Policy".Pharmacoeconomics. 2015 Sep;33(9):981-2. doi: 10.1007/s40273-015-0317-4. Pharmacoeconomics. 2015. PMID: 26224449 No abstract available.
-
Decision Thresholds for Medical Tests Under Ambiguity Aversion.Front Health Serv. 2022 Mar 21;2:825315. doi: 10.3389/frhs.2022.825315. eCollection 2022. Front Health Serv. 2022. PMID: 36925866 Free PMC article.
-
Decision Criterion and Value of Information Analysis: Optimal Aspirin Dosage for Secondary Prevention of Cardiovascular Events.Med Decis Making. 2018 May;38(4):427-438. doi: 10.1177/0272989X17746988. Epub 2018 Mar 12. Med Decis Making. 2018. PMID: 29529923 Free PMC article.
-
An investigation of the convergent validity and test-retest reliability of three uncertainty preference measures.Behav Res Methods. 2025 Jul 9;57(8):221. doi: 10.3758/s13428-025-02729-9. Behav Res Methods. 2025. PMID: 40634814 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources